a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Semaglutide begins to affect appetite early, but noticeable weight loss typically follows the dose-escalation phase
Finally, the role of GLP-1 in CSF secretion was overviewed because recent literature points to its clinical employment in treating IIH
Lee JY, Lee S, Choi JH, Na K
Archives of ophthalmology
The two most popular options, semaglutide and tirzepatide , have different mechanisms and produce somewhat different transformation patterns